Legumain in cardiovascular disease: Culprit or ally?
Publication date
2020-03
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Biomarkers, Legumain, Macrophages, Cysteine Endopeptidases, Cardiovascular Diseases, Anti-Inflammatory Agents, Humans, Taverne, Cardiology and Cardiovascular Medicine, Editorial, Comment
Citation
de Jager, S C & Hoefer, I E 2020, 'Legumain in cardiovascular disease : Culprit or ally?', Atherosclerosis, vol. 296, pp. 66-67. https://doi.org/10.1016/j.atherosclerosis.2020.01.007